Summit Therapeutics

Summit Therapeutics Current Assets

The Current Assets of Summit Therapeutics (SMMT) as of Nov 22, 2026 is 423.19 M USD. In the previous year, Current Assets was 189.71 M USD — a change of 123.07% (higher).

Current Assets

423.19 MUSD

YoY

123.07%

Last updated:

Current Assets of Summit Therapeutics is 2024 423.19 M USD. Current Assets of Summit Therapeutics was 2023 189.71 M USD. It decreases by 123.07% higher compared to the previous year.

The Summit Therapeutics Current Assets history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Assets
Date
Current Assets
Jan 1, 2018
61.20 M USD
Jan 1, 2019
79.60 M USD
Jan 1, 2020
87.60 M USD
Jan 1, 2021
97.40 M USD
Jan 1, 2022
656.70 M USD
Jan 1, 2023
189.71 M USD
Jan 1, 2024
423.19 M USD
Jan 1, 2025 (e)
720.30 M USD
The Summit Therapeutics Current Assets history
YEARCurrent AssetsYoY
est720.30 MUSD+70.21%
423.19 MUSD+123.07%
189.71 MUSD-71.11%
656.70 MUSD+574.23%
97.40 MUSD+11.19%
87.60 MUSD+10.05%
79.60 MUSD+30.07%
61.20 MUSD+20.47%
50.80 MUSD+271.07%
13.69 MUSD+227.51%
4.18 MUSD+21.16%
3.45 MUSD-44.80%
6.25 MUSD+37.97%
4.53 MUSD-60.47%
11.46 MUSD-39.30%
18.88 MUSD+45.45%
12.98 MUSD-8.66%
14.21 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Current Assets of Summit Therapeutics is 423.19 M USD in 2024.

Current Assets of Summit Therapeutics changed from 189.71 M USD to 423.19 M USD, representing a 123.07% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Current Assets Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Current assets are assets expected to be converted to cash within one year, including cash, receivables, and inventory.

Current Assets's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Assets's Summit Therapeutics historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Summit Therapeutics

All Key Metrics — Summit Therapeutics